retatrutide clinical trials phase 2 Retatrutide—A Game Changer in Obesity Pharmacotherapy eli lilly phase 3 trial

Beyond these maximums, additional benefits are unlikely and side effects (nausea, dehydration, pancreatitis risk) increase

For a category that has attracted significant FDA scrutiny in 2026, that level of structural transparency is not a minor detail - it is a baseline expectation that fewer platforms meet than the volume of advertising in this space would suggest

Because retatrutide has a half-life of approximately 6 days and is dosed once weekly, you return to each site roughly every 4 weeks when following a structured rotation

Dehydroepiandrosterone: molecular mechanisms and therapeutic implications in osteoarthritis

AASLD, American Association for the Study of Liver Diseases

But those numbers reflect the payers internal decision clock